Identification of a novel HA conformational change inhibitor of human influenza virus
Identifieur interne : 001A25 ( Main/Exploration ); précédent : 001A24; suivant : 001A26Identification of a novel HA conformational change inhibitor of human influenza virus
Auteurs : J. Yoshimoto [Japon] ; M. Kakui [Japon] ; H. Iwasaki [Japon] ; T. Fujiwara [Japon] ; H. Sugimoto [Japon] ; N. Hattori [Japon]Source :
- Archives of Virology [ 0304-8608 ] ; 1999-05-01.
Abstract
Summary: Stachyflin is a novel compound having H1 and H2 subtype-specific anti-influenza A virus activity. Stachyflin has no inhibition on H3 subtype influenza A or influenza B viruses. The susceptibility of the reassortant viruses between H1 and H3 subtype influenza A viruses to Stachyflin indicated that its target was virus-encoded hemagglutinin (HA). The results of the timing of Stachyflin addition against in vitro virus infection and virus-mediated hemolysis assay suggested that the drug inhibited the HA-mediated virus-cell fusion process. More directly, Stachyflin interfered with HA conformational change induced by low pH or heat treatment. The effect of Stachyflin could not be eliminated by washing of the Stachyflin-treated virus, which caused very specific virucidal effect. This is a remarkable property among small molecules which inhibit low-pH induced HA conformational change. From these findings, we concluded that the mechanism of Stachyflin action is to inhibit HA conformational change which is necessary for virus-cell membrane fusion. Stachyflin may be used as a tool for a study of molecular mechanism of low-pH induced HA conformational change, and offers potential as a pharmaceutical agent.
Url:
DOI: 10.1007/s007050050552
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000249
- to stream Istex, to step Curation: 000249
- to stream Istex, to step Checkpoint: 000825
- to stream Main, to step Merge: 001A72
- to stream Main, to step Curation: 001A25
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification of a novel HA conformational change inhibitor of human influenza virus</title><author><name sortKey="Yoshimoto, J" sort="Yoshimoto, J" uniqKey="Yoshimoto J" first="J." last="Yoshimoto">J. Yoshimoto</name></author><author><name sortKey="Kakui, M" sort="Kakui, M" uniqKey="Kakui M" first="M." last="Kakui">M. Kakui</name></author><author><name sortKey="Iwasaki, H" sort="Iwasaki, H" uniqKey="Iwasaki H" first="H." last="Iwasaki">H. Iwasaki</name></author><author><name sortKey="Fujiwara, T" sort="Fujiwara, T" uniqKey="Fujiwara T" first="T." last="Fujiwara">T. Fujiwara</name></author><author><name sortKey="Sugimoto, H" sort="Sugimoto, H" uniqKey="Sugimoto H" first="H." last="Sugimoto">H. Sugimoto</name></author><author><name sortKey="Hattori, N" sort="Hattori, N" uniqKey="Hattori N" first="N." last="Hattori">N. Hattori</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:23B352D5518AF38A2976BC28D266B92B7C42B326</idno><date when="1999" year="1999">1999</date><idno type="doi">10.1007/s007050050552</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-JW8BS4G7-Q/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000249</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000249</idno><idno type="wicri:Area/Istex/Curation">000249</idno><idno type="wicri:Area/Istex/Checkpoint">000825</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000825</idno><idno type="wicri:doubleKey">0304-8608:1999:Yoshimoto J:identification:of:a</idno><idno type="wicri:Area/Main/Merge">001A72</idno><idno type="wicri:Area/Main/Curation">001A25</idno><idno type="wicri:Area/Main/Exploration">001A25</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Identification of a novel HA conformational change inhibitor of human influenza virus</title><author><name sortKey="Yoshimoto, J" sort="Yoshimoto, J" uniqKey="Yoshimoto J" first="J." last="Yoshimoto">J. Yoshimoto</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Shionogi Discovery Research Laboratories, Osaka, Japan</wicri:regionArea><wicri:noRegion>Japan</wicri:noRegion></affiliation></author><author><name sortKey="Kakui, M" sort="Kakui, M" uniqKey="Kakui M" first="M." last="Kakui">M. Kakui</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Shionogi Discovery Research Laboratories, Osaka, Japan</wicri:regionArea><wicri:noRegion>Japan</wicri:noRegion></affiliation></author><author><name sortKey="Iwasaki, H" sort="Iwasaki, H" uniqKey="Iwasaki H" first="H." last="Iwasaki">H. Iwasaki</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Shionogi Discovery Research Laboratories, Osaka, Japan</wicri:regionArea><wicri:noRegion>Japan</wicri:noRegion></affiliation></author><author><name sortKey="Fujiwara, T" sort="Fujiwara, T" uniqKey="Fujiwara T" first="T." last="Fujiwara">T. Fujiwara</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Shionogi Discovery Research Laboratories, Osaka, Japan</wicri:regionArea><wicri:noRegion>Japan</wicri:noRegion></affiliation></author><author><name sortKey="Sugimoto, H" sort="Sugimoto, H" uniqKey="Sugimoto H" first="H." last="Sugimoto">H. Sugimoto</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Shionogi Discovery Research Laboratories, Osaka, Japan</wicri:regionArea><wicri:noRegion>Japan</wicri:noRegion></affiliation></author><author><name sortKey="Hattori, N" sort="Hattori, N" uniqKey="Hattori N" first="N." last="Hattori">N. Hattori</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Shionogi Discovery Research Laboratories, Osaka, Japan</wicri:regionArea><wicri:noRegion>Japan</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Archives of Virology</title><title level="j" type="abbrev">Arch. Virol.</title><idno type="ISSN">0304-8608</idno><idno type="eISSN">1432-8798</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Vienna</pubPlace><date type="published" when="1999-05-01">1999-05-01</date><biblScope unit="volume">144</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="865">865</biblScope><biblScope unit="page" to="878">878</biblScope></imprint><idno type="ISSN">0304-8608</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0304-8608</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Summary: Stachyflin is a novel compound having H1 and H2 subtype-specific anti-influenza A virus activity. Stachyflin has no inhibition on H3 subtype influenza A or influenza B viruses. The susceptibility of the reassortant viruses between H1 and H3 subtype influenza A viruses to Stachyflin indicated that its target was virus-encoded hemagglutinin (HA). The results of the timing of Stachyflin addition against in vitro virus infection and virus-mediated hemolysis assay suggested that the drug inhibited the HA-mediated virus-cell fusion process. More directly, Stachyflin interfered with HA conformational change induced by low pH or heat treatment. The effect of Stachyflin could not be eliminated by washing of the Stachyflin-treated virus, which caused very specific virucidal effect. This is a remarkable property among small molecules which inhibit low-pH induced HA conformational change. From these findings, we concluded that the mechanism of Stachyflin action is to inhibit HA conformational change which is necessary for virus-cell membrane fusion. Stachyflin may be used as a tool for a study of molecular mechanism of low-pH induced HA conformational change, and offers potential as a pharmaceutical agent.</div></front></TEI><affiliations><list><country><li>Japon</li></country></list><tree><country name="Japon"><noRegion><name sortKey="Yoshimoto, J" sort="Yoshimoto, J" uniqKey="Yoshimoto J" first="J." last="Yoshimoto">J. Yoshimoto</name></noRegion><name sortKey="Fujiwara, T" sort="Fujiwara, T" uniqKey="Fujiwara T" first="T." last="Fujiwara">T. Fujiwara</name><name sortKey="Hattori, N" sort="Hattori, N" uniqKey="Hattori N" first="N." last="Hattori">N. Hattori</name><name sortKey="Iwasaki, H" sort="Iwasaki, H" uniqKey="Iwasaki H" first="H." last="Iwasaki">H. Iwasaki</name><name sortKey="Kakui, M" sort="Kakui, M" uniqKey="Kakui M" first="M." last="Kakui">M. Kakui</name><name sortKey="Sugimoto, H" sort="Sugimoto, H" uniqKey="Sugimoto H" first="H." last="Sugimoto">H. Sugimoto</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A25 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A25 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:23B352D5518AF38A2976BC28D266B92B7C42B326
|texte= Identification of a novel HA conformational change inhibitor of human influenza virus
}}
| This area was generated with Dilib version V0.6.33. |  |